Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn's Disease. (Q45955692)

18 December 2017

title

Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn's Disease. (English)

1 reference

18 December 2017

1 reference

Maike Anna Michaels

1

1 reference

18 December 2017

Sebastian Torben Jendrek

2

1 reference

18 December 2017

Tobias Korf

3

1 reference

18 December 2017

Thomas Nitzsche

4

1 reference

18 December 2017

Bianca Teegen

5

1 reference

18 December 2017

Lars Komorowski

6

1 reference

18 December 2017

Stefanie Derer

7

1 reference

18 December 2017

Torsten Schröder

8

1 reference

18 December 2017

Florian Baer

9

1 reference

18 December 2017

Henrik Lehnert

10

1 reference

18 December 2017

Jürgen Büning

11

1 reference

18 December 2017

Klaus Fellerman

12

1 reference

18 December 2017

Christian Sina

13

1 reference

18 December 2017

publication date

13 August 2015

1 reference

18 December 2017

Inflammatory Bowel Diseases

published in

1 reference

18 December 2017

volume

21

1 reference

18 December 2017

issue

12

1 reference

18 December 2017

page(s)

2864-2872

1 reference

18 December 2017

cites work

Advances in IBD genetics

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

Evaluation of the combined application of ethanol-fixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

Pancreatic autoantibodies and autoantibodies against goblet cells in pediatric patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

Autoantibodies against exocrine pancreas in Crohn's disease are directed against two antigens: the glycoproteins CUZD1 and GP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

Pancreatic Autoantibodies in Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

The pancreatic zymogen granule membrane protein, GP2, binds Escherichia coli Type 1 fimbriae

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

The zymogen granule protein 2 (GP2) binds to scavenger receptor expressed on endothelial cells I (SREC-I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

Glycoprotein 2 (GP2): grabbing the FimH bacteria into M cells for mucosal immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000564

10.1097/MIB.0000000000000564

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017